Scholars Central

Conference abstractPublished 19 Oct 2017

HuAL1 peptide from complementarity-determining region 1 (CDR-1) of mAb HuA induces necroptosis in B16F10-Nex2 cells

Authors: Denise C Arruda, Felipe V Pereira, Luana C P Santos, Filipe M Melo, Aline N Rabaca, Elaine G Rodrigues, Renato A Mortara, Luciano Polonelli, Luiz R Travassos

Universidades de Mogi das Cruzes, Brazil University of SÃ?Â?Ã?£o Paulo, Brazil Federal University of SÃ?Â?Ã?£o Paulo, Brazil University of Parma, Italy

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Treatment of melanoma, mainly on the metastatic stage, is a great clinical challenge because conventional chemotherapy is rather ineffective. Other strategies, including immunotherapy, have been introduced and are very encouraging. We have previously shown that peptides derived from complementarity determining regions of immunoglobulins (CDRs) display antimicrobial and antitumor activities regardless of the specificity of the antibodies they were derived from. In the present study, we show that CDR 1 from the light chain (L1) of a human IgM, mAb (HuA), specific for difucosyl human blood group A (HuA) induces necroptotic cell death in the murine melanoma cell line B16F10-Nex2 and in other murine and human tumor cell lines. HuAL1 did not exert cytotoxic effects in non-tumorigenic cell lines. Melanoma cells treated with HuAL1 showed DNA degradation, propidium iodide incorporation and abundant superoxide anion production. Moreover, peptide treatment induced mitochondrial swelling and disruption of mitochondrial cristae. All these effects were caspaseindependent and RIPK1- and MLKL-dependent, since cell death was abolished when cells were co-incubated with necrostatin or necrosulfonamide. Confocal microscopy showed that HuAL1 peptide localizes to the cell nucleus, and ELISA assay showed that it probably binds to H3 histone. We propose that necroptosis is induced after chromatin disorganization upon peptide binding to histone. Our results show, for the first time, that a peptide derived from an Ig-CDR can induce necroptotic cell death on tumor cells.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Denise C Arruda”
  • BylineArticles whose byline prints “Felipe V Pereira”
  • BylineArticles whose byline prints “Luana C P Santos”
  • BylineArticles whose byline prints “Filipe M Melo”
  • BylineArticles whose byline prints “Aline N Rabaca”
  • BylineArticles whose byline prints “Elaine G Rodrigues”
  • BylineArticles whose byline prints “Renato A Mortara”
  • BylineArticles whose byline prints “Luciano Polonelli”